These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 24506885)

  • 1. Histone variants enriched in oocytes enhance reprogramming to induced pluripotent stem cells.
    Shinagawa T; Takagi T; Tsukamoto D; Tomaru C; Huynh LM; Sivaraman P; Kumarevel T; Inoue K; Nakato R; Katou Y; Sado T; Takahashi S; Ogura A; Shirahige K; Ishii S
    Cell Stem Cell; 2014 Feb; 14(2):217-27. PubMed ID: 24506885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Histone Variants TH2A and TH2B Enhance Human Induced Pluripotent Stem Cell Generation.
    Huynh LM; Shinagawa T; Ishii S
    Stem Cells Dev; 2016 Feb; 25(3):251-8. PubMed ID: 26649967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and functional analyses of nucleosome complexes with mouse histone variants TH2a and TH2b, involved in reprogramming.
    Padavattan S; Shinagawa T; Hasegawa K; Kumasaka T; Ishii S; Kumarevel T
    Biochem Biophys Res Commun; 2015 Aug; 464(3):929-35. PubMed ID: 26188507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells.
    Kunitomi A; Yuasa S; Sugiyama F; Saito Y; Seki T; Kusumoto D; Kashimura S; Takei M; Tohyama S; Hashimoto H; Egashira T; Tanimoto Y; Mizuno S; Tanaka S; Okuno H; Yamazawa K; Watanabe H; Oda M; Kaneda R; Matsuzaki Y; Nagai T; Okano H; Yagami KI; Tanaka M; Fukuda K
    Stem Cell Reports; 2016 Jun; 6(6):825-833. PubMed ID: 27237376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xist repression shows time-dependent effects on the reprogramming of female somatic cells to induced pluripotent stem cells.
    Chen Q; Gao S; He W; Kou X; Zhao Y; Wang H; Gao S
    Stem Cells; 2014 Oct; 32(10):2642-56. PubMed ID: 24965076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCNT versus iPSCs: proteins and small molecules in reprogramming.
    Han F; Li X; Song D; Jiang S; Xu Q; Zhang Y
    Int J Dev Biol; 2015; 59(4-6):179-86. PubMed ID: 26505250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of the inactive X chromosome and post-transcriptional reprogramming of Xist in iPSCs.
    Kim JS; Choi HW; Araúzo-Bravo MJ; Schöler HR; Do JT
    J Cell Sci; 2015 Jan; 128(1):81-7. PubMed ID: 25380819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.
    Brix J; Zhou Y; Luo Y
    J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xist Intron 1 Repression by Transcriptional-Activator-Like Effectors Designer Transcriptional Factor Improves Somatic Cell Reprogramming in Mice.
    Zhang J; Gao X; Yang J; Fan X; Wang W; Liang Y; Fan L; Han H; Xu X; Tang F; Bao S; Liu P; Li X
    Stem Cells; 2019 May; 37(5):599-608. PubMed ID: 30353613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency.
    Sridharan R; Gonzales-Cope M; Chronis C; Bonora G; McKee R; Huang C; Patel S; Lopez D; Mishra N; Pellegrini M; Carey M; Garcia BA; Plath K
    Nat Cell Biol; 2013 Jul; 15(7):872-82. PubMed ID: 23748610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone chaperone APLF regulates induction of pluripotency in murine fibroblasts.
    Syed KM; Joseph S; Mukherjee A; Majumder A; Teixeira JM; Dutta D; Pillai MR
    J Cell Sci; 2016 Dec; 129(24):4576-4591. PubMed ID: 27875275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
    van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
    Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Going up the hill: chromatin-based barriers to epigenetic reprogramming.
    Arabacı DH; Terzioğlu G; Bayırbaşı B; Önder TT
    FEBS J; 2021 Aug; 288(16):4798-4811. PubMed ID: 33190371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced telomere rejuvenation in pluripotent cells reprogrammed via nuclear transfer relative to induced pluripotent stem cells.
    Le R; Kou Z; Jiang Y; Li M; Huang B; Liu W; Li H; Kou X; He W; Rudolph KL; Ju Z; Gao S
    Cell Stem Cell; 2014 Jan; 14(1):27-39. PubMed ID: 24268696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mechanical stimulation on the reprogramming of somatic cells into human-induced pluripotent stem cells.
    Kim YM; Kang YG; Park SH; Han MK; Kim JH; Shin JW; Shin JW
    Stem Cell Res Ther; 2017 Jun; 8(1):139. PubMed ID: 28595633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic Acid Enhances iPSC Induction From Human Bone Marrow-Derived Cells Through the Suppression of Reprogramming-Induced Senescence.
    Chen X; Zhai Y; Yu D; Cui J; Hu JF; Li W
    J Cell Physiol; 2016 Aug; 231(8):1719-27. PubMed ID: 26620855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic expression of reprogramming factors enhances the development of cloned porcine embryos.
    Song Z; Ji Q; Zhao H; Nie Y; He Z; Chen Y; Cong P
    Biotechnol Lett; 2014 Oct; 36(10):1953-61. PubMed ID: 24930113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of pluripotent stem cells from primordial germ cells by single reprogramming factors.
    Nagamatsu G; Kosaka T; Saito S; Honda H; Takubo K; Kinoshita T; Akiyama H; Sudo T; Horimoto K; Oya M; Suda T
    Stem Cells; 2013 Mar; 31(3):479-87. PubMed ID: 23255173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox2 expression effects on direct reprogramming efficiency as determined by alternative somatic cell fate.
    Yamaguchi S; Hirano K; Nagata S; Tada T
    Stem Cell Res; 2011 Mar; 6(2):177-86. PubMed ID: 21130722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.